Skip to search formSkip to main contentSkip to account menu

N-bromoacetyl-4-azido-L-phenylalanine methyl ester

Known as: BAPM, L-Phenylalanine, 4-azido-N-(bromoacetyl)-, methyl ester, N-bromoacetyl-p-azido-L-phenylalanine methyl ester 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Azides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
G204(P) Two year outcome of infants born ≥32 weeks gestation and ≤1500g
Aims It is a BAPM recommendation that infants with a birth weight of ≤1500 g have a standardised neurodevelopmental outcome… 
2013
2013
Estimating Capital Cost of Project in the Inefficient Market
The method for estimating capital cost of p roject based on CAPM does not work in the inefficient market. According to frameworks… 
2012
2012
Study on noise trading in Chinese stock market based on BAPM model
Excessive noise trading, especially those subject to administrative penalties listed noise traders in China's securities market… 
Review
2012
Review
2012
Cerebral function monitoring during therapeutic hypothermia in a tertiary neonatal centre
Introduction Therapeutic hypothermia is a standard of care in the UK for neonates with hypoxic ischaemic encephalopathy. Meeting… 
2011
2011
The Measure of NTR in BAPM Model
In the CAPM model,market risks include market risk reward level presented by βCAPM and Noise Trader Risk(NTR).The residual method… 
Review
2011
Review
2011
Routine cranial ultrasound scanning in tertiary neonatal units
Background Cranial ultrasound scans (CUSS) are widely used to identify babies at later risk of serious disability. There is no… 
2010
2010
A Study of the Cost of Corporate Equity Capital Based on BAPM
In Behavioral Asset Pricing Model(BAPM),the cost of stock equity capital relates to the behaviorβ.In non-effective market,the… 
2005
2005
269 Nasal Continuous Positive Airway Pressure Facilitates Early Neonatal Back Transfer
Introduction: Neonatal networks and dedicated intensive care retrieval systems are evolving in the United Kingdom. Early back… 
2004
2004
BAPM Guidelines for Vetilatory Management
1983
1983
Specific labeling of the active site of cytosolic aspartate aminotransferase through the use of a cofactor analogue, N-(Bromoacetyl)pyridoxamine.
The cofactor analogue N-(bromoacetyl)pyridoxamine (BAPM) has been employed to inactivate the cytosolic isozyme of apo-aspartate…